SPOTLIGHT -
J&J to Cut Costs and Jobs
Company follows industry's job-slashing trend
Pfizer Fires Three?
Pharma giant's house gets a little cleaner after whistle-blower's accusations
Avandia Survives
Advisory committees recommend that the popular diabetes drug remain on the market--but with new warnings
